Meeting
2021 ASCO Annual Meeting
Regorafenib (R) in advanced solitary fibrous tumor (SFT): Results from an exploratory phase II clinical study.
Authors
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Silvia Stacchiotti , Giacomo Giulio Baldi , Salvatore Lo Vullo , Carlo Morosi , Francesca Gabriella Greco , Paola Collini , Marta Barisella , Gianpaolo Dagrada , Nadia Zaffaroni , Alessandro Gronchi , Noemi Simeone , Luigi Mariani , Anna Maria Frezza , Paolo Giovanni Casali
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Clinical Trial Registration Number
2015-002629-21
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 11558)
DOI
10.1200/JCO.2021.39.15_suppl.11558
Abstract #
11558
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).
First Author: Silvia Stacchiotti
Poster
2019 ASCO Annual Meeting
Multi-institutional european single-arm phase II trial of pazopanib in advanced typical solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.
First Author: Josefina Cruz Jurado
Poster
2017 ASCO Annual Meeting
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.
First Author: Silvia Stacchiotti
Poster
2021 ASCO Annual Meeting
Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) (CaNI) for advanced renal cell carcinoma with variant histology (aRCCVH).
First Author: Bradley Alexander McGregor